News - Page 261 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Field Trip Psychedelics Inc. Expands Stateside With Psychedelic-Enhanced Psychotherapy Clinic in New York City

Field Trip Psychedelics Inc. Expands Stateside With Psychedelic-Enhanced Psychotherapy Clinic in New York City

Post published:August 13, 2020
Post category:Press Release

Read more about the article Yield Growth Announces Name Change and Provides Corporate Update

Yield Growth Announces Name Change and Provides Corporate Update

Post published:August 13, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group Provides Inaugural Corporate Update in the Expanding Psychedelic Medicines Sector

Mydecine Innovations Group Provides Inaugural Corporate Update in the Expanding Psychedelic Medicines Sector

Post published:August 12, 2020
Post category:Press Release

Read more about the article Revive Therapeutics Advancing Drug Delivery Technology for Psychedelics

Revive Therapeutics Advancing Drug Delivery Technology for Psychedelics

Post published:August 11, 2020
Post category:Press Release

Read more about the article PharmaDrug Inc. Enters into Definitive Agreement to Acquire First Smart Shop in the Netherlands

PharmaDrug Inc. Enters into Definitive Agreement to Acquire First Smart Shop in the Netherlands

Post published:August 11, 2020
Post category:Press Release

Read more about the article Hollister Biosciences Inc. Closes $1.5 Million Private Placement Financing

Hollister Biosciences Inc. Closes $1.5 Million Private Placement Financing

Post published:August 11, 2020
Post category:Press Release

Read more about the article MindMed Adds Psychedelic Assisted Therapy Expert Dr. Peter Gasser As Clinical Advisor For Project Lucy

MindMed Adds Psychedelic Assisted Therapy Expert Dr. Peter Gasser As Clinical Advisor For Project Lucy

Post published:August 6, 2020
Post category:Press Release

Read more about the article NeonMind Submits Application for Psilocybin Research to Health Canada

NeonMind Submits Application for Psilocybin Research to Health Canada

Post published:August 6, 2020
Post category:Press Release

Read more about the article Amadeus Diamond, The Entheos Foundation

Amadeus Diamond, The Entheos Foundation

Post published:August 6, 2020
Post category:Interview

Read more about the article Revive Therapeutics Update Following U.S. FDA Approval of Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Update Following U.S. FDA Approval of Phase 3 Clinical Trial for Bucillamine in COVID-19

Post published:August 5, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.